SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (4774)7/7/1998 1:43:00 AM
From: Steve Fancy  Read Replies (1) of 6136
 
Izzy, I don't mean to raise your blood pressure. I'm an options person at heart, who just happens to have some AGPH stock still hanging around from the old days. By my nature, I look for explanations for all stock movements.

The DW-MS report read as if they received guidance from AGPH on the timing of up front licensing fees. If this is the case, AGPH owes us the same courtesy by law. I'll try writing them. FWIW they maintained an "Outperform", not a buy. I believe they were downgraded from buy several months ago, but could be wrong....regardless, the current rating was maintained.

I agree with Bill that at some point the bad news (or perception of) should be washed out. I really think we're seeing some downward pressure from AGPH bears also, hopefully looking to finally cover their short positions.

I'll post any response I receive from AGPH.

sf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News